WHAT’S NEXT FOR NEKTAR THERAPEUTICS? $NKTR N
Post# of 68
(Total Views: 303)
Posted On: 03/21/2022 9:03:51 AM
WHAT’S NEXT FOR NEKTAR THERAPEUTICS?
$NKTR
Nektar Therapeutics (NASDAQ: NKTR) faced a setback with its crucial study of bempegaldesleukin in combination with Opdivo (nivolumab), failing to meet the primary endpoints of progression-free survival (PFS), objective response rate (ORR) and Overall Survival (OS).
What's next for the Company?
Read on to find out more!
https://www.aviseanalytics.com/whats-next-for...rapeutics/
$NKTR
Nektar Therapeutics (NASDAQ: NKTR) faced a setback with its crucial study of bempegaldesleukin in combination with Opdivo (nivolumab), failing to meet the primary endpoints of progression-free survival (PFS), objective response rate (ORR) and Overall Survival (OS).
What's next for the Company?
Read on to find out more!
https://www.aviseanalytics.com/whats-next-for...rapeutics/
(0)
(0)Nektar Therapeutics (NKTR) Stock Research Links
Scroll down for more posts ▼